BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26831104)

  • 1. TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS.
    Wang Y; Su L; Morin MD; Jones BT; Whitby LR; Surakattula MM; Huang H; Shi H; Choi JH; Wang KW; Moresco EM; Berger M; Zhan X; Zhang H; Boger DL; Beutler B
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):E884-93. PubMed ID: 26831104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
    Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
    J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
    Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide.
    Liu S; Gallo DJ; Green AM; Williams DL; Gong X; Shapiro RA; Gambotto AA; Humphris EL; Vodovotz Y; Billiar TR
    Infect Immun; 2002 Jul; 70(7):3433-42. PubMed ID: 12065483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfatides are endogenous ligands for the TLR4-MD-2 complex.
    Su L; Athamna M; Wang Y; Wang J; Freudenberg M; Yue T; Wang J; Moresco EMY; He H; Zor T; Beutler B
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34290146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance.
    Murphy M; Xiong Y; Pattabiraman G; Qiu F; Medvedev AE
    J Biol Chem; 2015 Jul; 290(31):19218-32. PubMed ID: 26082489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1-IKKϵ-IRF3 axis activation.
    Tsukamoto H; Takeuchi S; Kubota K; Kobayashi Y; Kozakai S; Ukai I; Shichiku A; Okubo M; Numasaki M; Kanemitsu Y; Matsumoto Y; Nochi T; Watanabe K; Aso H; Tomioka Y
    J Biol Chem; 2018 Jun; 293(26):10186-10201. PubMed ID: 29760187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
    Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
    Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gedunin Binds to Myeloid Differentiation Protein 2 and Impairs Lipopolysaccharide-Induced Toll-Like Receptor 4 Signaling in Macrophages.
    Borges PV; Moret KH; Maya-Monteiro CM; Souza-Silva F; Alves CR; Batista PR; Caffarena ER; Pacheco P; Henriques Md; Penido C
    Mol Pharmacol; 2015 Nov; 88(5):949-61. PubMed ID: 26330549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1.
    Yang H; Young DW; Gusovsky F; Chow JC
    J Biol Chem; 2000 Jul; 275(27):20861-6. PubMed ID: 10877845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways.
    Gorina R; Font-Nieves M; Márquez-Kisinousky L; Santalucia T; Planas AM
    Glia; 2011 Feb; 59(2):242-55. PubMed ID: 21125645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique properties of the chicken TLR4/MD-2 complex: selective lipopolysaccharide activation of the MyD88-dependent pathway.
    Keestra AM; van Putten JP
    J Immunol; 2008 Sep; 181(6):4354-62. PubMed ID: 18768894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
    Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH
    J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid A3 binds MD-2 to activate p38 and NF-κB pathways in a MyD88-dependent manner.
    Deguchi A; Tomita T; Omori T; Komatsu A; Ohto U; Takahashi S; Tanimura N; Akashi-Takamura S; Miyake K; Maru Y
    J Immunol; 2013 Aug; 191(4):1856-64. PubMed ID: 23858030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
    Andreakos E; Sacre SM; Smith C; Lundberg A; Kiriakidis S; Stonehouse T; Monaco C; Feldmann M; Foxwell BM
    Blood; 2004 Mar; 103(6):2229-37. PubMed ID: 14630816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner.
    Honda H; Nagai Y; Matsunaga T; Saitoh S; Akashi-Takamura S; Hayashi H; Fujii I; Miyake K; Muraguchi A; Takatsu K
    J Leukoc Biol; 2012 Jun; 91(6):967-76. PubMed ID: 22422925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C4b-binding protein negatively regulates TLR4/MD-2 response but not TLR3 response.
    Morita N; Yamazaki T; Murakami Y; Fukui R; Yamai I; Ichimonji I; Nakashima A; Nagaoka F; Takagi H; Miyake K; Akashi-Takamura S
    FEBS Lett; 2017 Jun; 591(12):1732-1741. PubMed ID: 28542817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics.
    Heine H; Adanitsch F; Peternelj TT; Haegman M; Kasper C; Ittig S; Beyaert R; Jerala R; Zamyatina A
    Front Immunol; 2021; 12():631797. PubMed ID: 33815382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol.
    Byrd-Leifer CA; Block EF; Takeda K; Akira S; Ding A
    Eur J Immunol; 2001 Aug; 31(8):2448-57. PubMed ID: 11500829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.